Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis

Figure 4 Ubiquitin-conjugating enzyme E2T silencing results in suppressed cell cycle progression in hepatocellular carcinoma cells. A and B: Cell cycle distribution analysis by flow cytometry indicating that ubiquitin-conjugating enzyme E2T (UBE2T) knockdown caused increased G1 phase and decreased S phase in SMMC-7721 cells. ^bP < 0.01; C and D: Cell cycle distribution analysis by flow cytometry indicating that UBE2T knockdown caused increased G1 phase and decreased S phase in BEL-7404 cells. ^bP < 0.01.